It is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.

What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.

CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.

Flower will continue to be the largest part of the legal cannabis market in the United States in 2022. Sales of flower are forecast to reach 14.1 billion U.S. dollars.

In December 2023, cannabis retail sales totaled 101 million U.S. dollars in Colorado. In the same month, medical sales reached 14.7 million dollars. The sales of both medical and recreational cannabis has been trending downward in the state since 2021.

By 2020, it has been estimated that 4.2 billion U.S. dollars of the United States' illicit cannabis sales will take place in the state of Texas. An estimated 2.2 billion U.S. dollars of illicit cannabis sales has been projected to take place in the state of North Carolina.

North America had, by far, the largest share of legal cannabis sales worldwide in 2020, accounting for nearly the entire market. Latin America had the smallest share at less than 0.01 percent.

Illicit cannabis made up the majority of the cannabis market in Germany in 2020. Sales of illicit cannabis totaled 13.1 billion U.S. dollars in that year and were expected to grow to 16.6 billion dollars by 2025. The coalition government formed after elections in Germany in 2021 plans to legalize cannabis for recreational use.

Generation Z witnessed the highest year-on-year sales growth of recreational cannabis between 2019 and 2020 in the United States, with sales increasing by approximately 127 percent for this generational cohort.

Cannabis flower gained market share in Colorado during the first six months of 2020. Over the same period, all other categories lost ground, with edibles being the most affected.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Retail sales of marijuana in the United States decreased from around 464 million U.S. dollars in January 2020 to reach around 382.65 million U.S. dollars in April 2020 during the coronavirus pandemic.

This statistic shows the cannabis market sales for recreational use (referred to by the source as adult use) in the United States in 2014 and 2015 and provides a forecast for 2020. The U.S. recreational use cannabis market sales amounted to 998 million U.S. dollars in 2015.

Cannabis flower and edibles gained market share in the state of Washington during the first six months of 2020. Over the same period, all other categories lost ground.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Sales of cannabis in Illinois reached nearly one billion dollars by September 20201. This already surpassed the total sales of 2020, the first year of legal adult use sales in the state.

California remained the largest legal cannabis market in the United States throughout the early months of the 2020 coronavirus outbreak. Sales in the state peaked in March at 320 million U.S. dollars while Nevada, which relies heavily on tourism for revenue, saw its peak of 56 million dollars in January before steadily declining in the following months as fewer people traveled.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Sales of legal adult-use cannabis in Maine rose to 10.2 million U.S. dollars in August of 2021, less than a year since legal sales began.

Adult use sales of cannabis in Michigan totaled over three billion U.S. dollars in 2023. This represented an increase of ten percent over the previous year.

Medical cannabis made up the majority of the legal cannabis market in Europe in 2020. Sales of legal adult use cannabis totaled 103.5 million U.S. dollars in that year and are expected to grow to 140.5 million dollars by 2025.

This statistic presents the tax revenue from marijuana in the United States in 2017, with a forecast for 2020. Taxable retail sales of medical and adult use marijuana are projected to reach approximately 1.8 billion U.S. dollars by 2020.

This statistic presents the tax revenue from marijuana compared to total state sales taxes in the United States in 2017, with a forecast for 2020. Taxable retail sales of marijuana are projected to reach approximately 1.4 billion U.S. dollars by 2020. Around 405 million U.S. dollars will be earned from state sales taxes.

Sales of legal cannabis grew during the outbreak of coronavirus in the United States in March 2020. At 42.1 percent, growth was particularly strong among Gen Z consumers. Conversely, sales declined for Baby Boomer consumers by 2.1 percent.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

According to the given figures, until now, the COVID-19 pandemic had no negative effect on medical cannabis sales in Oklahoma, Maryland, Illinois, and Ohio. Quite the contrary, amidst the first wave of the pandemic there was a slight increase in MMJ sales, while in Oklahoma sales growth was even significantly higher.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.